Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Celularity ( (CELU) ) just unveiled an announcement.
On June 23, 2025, Celularity Inc. entered into a securities purchase agreement with certain investors for a private placement of 739,286 shares of Class A common stock at $1.40 per share. The agreement also included a warrant adjustment for 1,311,093 warrants, revising the exercise price to $2.50 per share and extending the expiration date to June 30, 2030. The closing is expected during the week of July 21, 2025, with gross proceeds anticipated at $1,035,000, intended for working capital and general corporate purposes.
Spark’s Take on CELU Stock
According to Spark, TipRanks’ AI Analyst, CELU is a Neutral.
Celularity’s stock score is primarily influenced by its strong technical momentum, despite significant financial challenges. The company’s robust revenue growth is overshadowed by high leverage and ongoing unprofitability. Although the stock shows bullish momentum, its high RSI suggests potential overbought conditions. Valuation is weak due to negative earnings.
To see Spark’s full report on CELU stock, click here.
More about Celularity
Average Trading Volume: 223,208
Technical Sentiment Signal: Hold
Current Market Cap: $72.57M
Learn more about CELU stock on TipRanks’ Stock Analysis page.